title: Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
authors: Minh Patrick
authors: MP
authors: Lê
authors: Caroline
authors: C
authors: Solas
authors: Rodolphe
authors: R
authors: Garraffo
authors: Marie-Claude
authors: MC
authors: Gagnieu
authors: Patrice
authors: P
authors: Muret
authors: Patrick
authors: P
authors: Yeni
authors: Catherine
authors: C
authors: Dhiver
authors: Christine
authors: C
authors: Katlama
authors: Isabelle
authors: I
authors: Poizot-Martin
authors: Jacques
authors: J
authors: Durant
authors: Gilles
authors: G
authors: Peytavin
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D003510:Cyclohexanes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D000077592:Maraviroc; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009570:Nitriles; D010949:Plasma / Q000737:chemistry; D011724:Pyridazines / Q000008:administration & dosage / Q000493:pharmacokinetics*; D011743:Pyrimidines; D019438:Ritonavir / Q000008:administration & dosage; D014230:Triazoles / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D019380:Anti-HIV Agents; D003510:Cyclohexanes; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D014230:Triazoles; C451734:etravirine; D000077592:Maraviroc; D019438:Ritonavir